SMARCB1 and nasal cavity and paranasal sinus carcinoma: Loss of SMARCB1 because of biallelic inactivation of its gene in a subset of poorly or undifferentiated sinonasal carcinoma has been first described in 2014 by two independent groups, followed by a few additional series including one large multi-institutional series (n=39) [7, 8].